Comparing Wide- and Narrow-angle Digital Breast Tomosynthesis for Breast Masses
This observational study is comparing two types of Digital Breast Tomosynthesis (DBT) (a special type of mammogram that takes multiple images to create a 3D picture of the breast): wide-angle DBT and narrow-angle DBT. The main goal is to see if wide-angle DBT images are better at showing breast masses and architectural distortions (changes in the normal breast tissue pattern) than narrow-angle DBT. Researchers also want to gather feedback from radiologists and technologists, and understand participant comfort. You may be able to join if you are a woman having a standard screening mammogram and can understand and sign consent. Pregnant women and men cannot participate. The current recruitment status is unclear, and the study plans to enroll 100 participants.
- Study design
- This is an observational study planning to enroll 100 women. It compares two types of Digital Breast Tomosynthesis (DBT).
- What's involved
- You would undergo tomosynthesis imaging as part of your standard screening mammography.
- Compensation
- Not stated in the trial record.
- Follow-up
- Safety and adverse events (AEs) will be measured through study completion, which is an average of 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Beatriz Adrada, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Safety and adverse events (AEs)Through study completion; an average of 1 year
ncidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events